Provera Regimen for Menstrual Suppression During Umrah
For menstrual suppression during Umrah, administer oral medroxyprogesterone acetate 10 mg daily starting 3-5 days before the expected menstrual period and continuing throughout the pilgrimage duration. 1
Recommended Dosing Protocol
Timing of Initiation
- Start medroxyprogesterone acetate 3-5 days before the anticipated menstrual period to ensure adequate endometrial suppression before bleeding would typically begin 1
- The medication can be initiated at any time if secondary amenorrhea is already present 1
- For women with regular cycles, calculate the start date based on typical cycle length 1
Dosage
- 10 mg daily is the optimal dose for inducing secretory transformation and menstrual suppression 1
- This dose provides adequate endometrial stabilization to prevent breakthrough bleeding 1, 2
- Lower doses (5 mg) may be insufficient for reliable menstrual suppression in this context 1
Duration
- Continue daily administration throughout the entire Umrah period without interruption 1
- Do not discontinue until after returning from pilgrimage, as withdrawal bleeding typically occurs 3-7 days after stopping the medication 1
- Plan for at least 7-10 days of continuous use, extending as needed based on pilgrimage duration 1
Key Clinical Considerations
Expected Outcomes
- Menstrual suppression success rates are high when initiated before the expected period 2
- Approximately 75% of women achieve amenorrhea with continuous progestin therapy 2
- Breakthrough bleeding occurs in approximately 20% of users, particularly in the first cycle of use 2
Contraindications to Screen For
Before prescribing, ensure the patient does not have: 1
- Current pregnancy (perform pregnancy test if any uncertainty)
- Unusual vaginal bleeding of unknown cause
- Known or suspected breast cancer or other hormone-sensitive malignancies
- Active thromboembolism or history of thromboembolic disorders
- Active liver disease
- Known hypersensitivity to medroxyprogesterone acetate
Counseling Points
- Inform patients that withdrawal bleeding will occur 3-7 days after discontinuation, so they should plan accordingly after returning home 1
- Advise about potential side effects including breast tenderness, headache, bloating, and mood changes 1
- Emphasize the importance of not missing doses, as even one missed dose may trigger breakthrough bleeding 1
- This is NOT a contraceptive regimen—additional contraception is required if sexually active 1
Common Pitfalls to Avoid
Timing Errors
- Do not start too early (more than 5-7 days before expected menses), as this unnecessarily prolongs exposure and increases side effect risk without additional benefit 1
- Do not start after bleeding has already begun, as this will not reliably stop active menstruation and breakthrough bleeding becomes more likely 1
Dosing Mistakes
- Do not use 5 mg daily for menstrual suppression, as this lower dose is inadequate for reliable cycle control in this short-term context 1
- Do not use the injectable formulation (Depo-Provera 150 mg IM) for this indication, as it is designed for long-term contraception with effects lasting 3 months and potential delayed return to normal menses 3, 4
Inadequate Patient Preparation
- Do not assume all patients understand their cycle timing—many women cannot accurately predict their next period 5
- Have patients track their cycles for 2-3 months before travel if possible to improve timing accuracy 5
- Consider starting 1-2 days earlier if cycle regularity is uncertain 1
Alternative Consideration
While not Provera, combined oral contraceptives used continuously (skipping placebo pills) are an alternative approach with potentially better cycle control, but this requires ensuring no contraindications to estrogen-containing products 6